![](https://cdn.prod.website-files.com/64be4358a1f629e06a086be8/650d97a0228a93fe97e08fa4_Frontier-Risk-Insight-Header-Background-Image-03.jpg)
James Whitcomb, Frontier Risk’s CEO breaks down "Rescheduling" on FOX5 DC
A new federal study is calling for a major change in how the government classifies marijuana. The U.S. Department of Health and Human Services is now asking the Drug Enforcement Agency to "reschedule" cannabis, citing its widely-accepted medicinal use. James Whitcomb, CEO of Frontier Risk explain what "rescheduling" means and its potential impact here and across the nation in a recent interview on FOX5 Washington DC.
![James Whitcomb, Frontier Risk’s CEO breaks down 'reschedule' on FOX5 Washington DC](https://cdn.prod.website-files.com/64be4358a1f629e06a086be8/6503589029b19b58fcf0f4ff_Frontier-Risk-CEO-James-Whitcomb-on-FOX5-Washington.jpg)